Search company, investor...

American Pathology Partners

Founded Year



Series A - II | Alive

Total Raised


Last Raised

$6M | 11 yrs ago

About American Pathology Partners

American Pathology Partners is a network of pathology laboratories and practices dedicated to local and regional healthcare. Based on the individual needs of partner practices and laboratories, the company offers a wide array of world-class support services, including business support, access capital for liquidity and/or growth, and selected esoteric or subspecialty pathology services.

Headquarters Location

103 Continental Place Suite 400

Brentwood, Tennessee, 37027,

United States


Missing: American Pathology Partners's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: American Pathology Partners's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest American Pathology Partners News

MDxHealth and American Pathology Partners Announce Marketing Agreement for ConfirmMDx for Prostate Cancer

May 13, 2014

MDxHealth and American Pathology Partners Announce Marketing Agreement for ConfirmMDx for Prostate Cancer      May 13, 2014 02:07 | Source: MdxHealth (TM) IRVINE, Calif., and LIEGE, Belgium, May 13, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced that it has entered into a co-marketing agreement with American Pathology Partners to promote its ConfirmMDx® for Prostate Cancer test. American Pathology Partners is creating a nationwide network of leading anatomic pathology laboratories, with UniPath in Denver, Colorado, Palm Beach Pathology in West Palm Beach, Florida and Eastern Carolina Pathology in Wilson, North Carolina. The partnership expands MDxHealth's customer base to some of the nation's leading pathologists who serve urologists in key geographic markets within the United States. "Collaborating with leading pathology networks like American Pathology Partners is an integral component of our growth strategy," noted Dr. Jan Groen, CEO of MDxHealth. "As the urology community learns more about the clinical utility of ConfirmMDx for patient management decisions, increased access through valuable strategic partners is essential to deliver improved care to a larger number of patients. "  About ConfirmMDx® for Prostate Cancer Over 975,000 American men receive a negative prostate biopsy result each year, though approximately 25% of these men may still harbor occult prostate cancer. This well-documented risk of undetected cancer, often with clinically significant Gleason scores, leads to a high rate of repeat biopsies with greater than 40% of men receiving at least one repeat biopsy, and many receiving a 3rd and 4th biopsy. Today's gold standard diagnostic approach is the prostate biopsy procedure, collecting 10-12 needle core biopsy samples; however this sampling represents less than 1% of a man's prostate. ConfirmMDx for Prostate Cancer is an epigenetic assay to help urologists distinguish patients who have a true-negative biopsy from those at risk for occult cancer. The test is able to detect an epigenetic field effect or "halo" associated with the cancerization process at the DNA level. This molecular "halo" around a cancer lesion can be present despite having a normal appearance under the microscope. The test helps urologists rule out prostate cancer-free men from undergoing unnecessary repeat biopsies and rule in high-risk patients who may require repeat biopsies and potential treatment. Performance of the proprietary ConfirmMDx genes and technology has been published in 42 studies with over 4,100 patients tested. About American Pathology Partners American Pathology Partners is an emerging nationwide network of leading anatomic pathology laboratories serving physician offices, hospitals, and surgery centers. Founded in early 2008, APP provides academic-caliber medical consults and interpretation services through its affiliated pathologists. APP's board-certified pathologist partners have extensive training and experience in numerous subspecialty areas, including surgical pathology, cytopathology, dermatopathology, hematopathology, urologic pathology, gastrointestinal and liver pathology, nephropathology, pediatric and perinatal pathology, immunopathology, and molecular diagnostics. Additional information can be found at . About MDxHealth MDxHealth is a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment. The company's tests are based on proprietary gene methylation (epigenetics) technology and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information visit and follow us on Twitter at . For more information:

American Pathology Partners Frequently Asked Questions (FAQ)

  • When was American Pathology Partners founded?

    American Pathology Partners was founded in 2008.

  • Where is American Pathology Partners's headquarters?

    American Pathology Partners's headquarters is located at 103 Continental Place, Brentwood.

  • What is American Pathology Partners's latest funding round?

    American Pathology Partners's latest funding round is Series A - II.

  • How much did American Pathology Partners raise?

    American Pathology Partners raised a total of $7M.

  • Who are the investors of American Pathology Partners?

    Investors of American Pathology Partners include New Enterprise Associates.

  • Who are American Pathology Partners's competitors?

    Competitors of American Pathology Partners include United Surgical Partners International, Foundation Radiology Group, BioTelemetry, Shearwater Health, Upstream Rehabilitation, Aptus Health, Critical Signal Technologies, Paradigm, Specialized Medical Services, Telemedicine Clinic and 45 more.

Compare American Pathology Partners to Competitors

Ardent Health Services

Ardent Health Services, previously known as Behavioral Healthcare, invests in people, technology, facilities, and communities, producing high-quality care and extraordinary results. Ardent currently operates three health systems with a range of hospitals and employs multi-specialty physicians in multiple clinic locations across New Mexico, Oklahoma, and Texas. The company was founded in 1993 and is based in Nashville, Tennessee.

U.S. Renal Care Logo
U.S. Renal Care

U.S. Renal Care clinics provide in-center and at-home hemodialysis and peritoneal dialysis services for end-stage renal disease. The company also manages several acute setting dialysis programs in conjunction with local community hospitals. The company was founded in 2000 and is based in Plano, Texas.

United Emergency Services

United Emergency Services (UES) is a physician contract management company that focuses on providing experienced emergency department physicians and other health care providers to single hospital communities in the Southeastern United States.

TriMedx Logo

TriMedx is a provider of clinical engineering services. Created by healthcare for healthcare, TriMedx understands that patients are the number one priority. Headquartered in Indianapolis, TriMedx started as a hospital clinical engineering department focusing on reducing expenses, optimizing service and enhancing the patient experience through innovative medical equipment management programs. Today, TriMedx is recognized around the globe as a leader in healthcare technology management. The company was founded in 1998 and is based in Indianapolis, Indiana.

Concentra Logo

Concentra provides health care services. It offers vaccinations, occupational medicine, urgent care, physical therapy, test, and screening services. The company was founded in 1979 and is based in Addison, Texas.

MJ Group

MJ Group offers is a provider of healthcare check-up services

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.